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Background: In this study, we examined the effects of various enzymes on chemical conversions of
ginsenosides in ginseng extract prepared by amylases.
Methods: Rapidase, Econase CE, Viscozyme, Ultraﬂo L, and Cytolase PCL5 were used for secondary
enzymatic hydrolysis after amylase treatment of ginseng extract, and ginsenoside contents, skin
permeability, and chemical compositions including total sugar, acidic polysaccharide, and polyphenols
were determined on the hydrolyzed ginseng extract.
Results: Rapidase treatment signiﬁcantly elevated total ginsenoside contents compared with the control
(p < 0.05). In particular, deglycosylated ginsenosides including Rg3, which are known as bioactive
compounds, were signiﬁcantly increased after Rapidase treatment (p < 0.05). The Rapidase-treated
group also increased the skin permeability of polyphenols compared with the control, showing the
highest level of total sugar content among the enzyme treatment groups.
Conclusion: This result showed that Rapidase induced the conversion of ginsenoside glycosides to
aglycones. Meanwhile, Cytolase PCL5 and Econase treatments led to a signiﬁcant increase of uronic acid
(acidic polysaccharide) level. Taken together, our data showed that the treatments of enzymes including
Rapidase are useful for the conversion and increase of ginsenosides in ginseng extracts or products.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Ginseng (the roots of Panax ginsengMeyer, Araliaceae) has been
usually used as a traditional herbal medicine in Asian countries. The
major components of ginseng are ginsenosides, which are glyco-
sides with a dammarane skeleton aglycone [1,2]. These ginseno-
sides have been reported to show various biological activities
including anti-inﬂammatory [3] and antitumor effects [4,5]. The
pharmacological actions of these ginsenosides have been explained
by the biotransformation of ginsenosides by human intestinal
bacteria [6e8].
Ginsenosides, glycosides with steroids or triterpenes as agly-
cones, are an important class of physiologically active compounds
occurring in many herbs. Recent studies showed that the sugar
chains of ginsenosides are closely related to the biological activityutrition, Korea University, 161 Jeon
erms of the Creative Commons At
ribution, and reproduction in any
e Korean Society of Ginseng, Publof ginsenosides, and modiﬁcation of the sugar chains makes a dif-
ference to the biological activity [9e12].
Several studies have shown that removal of the glycosyl group
in ginsenosides is required for enhancement of physiological action
of ginsenosides [13]. Various transformation methods including
mild acid hydrolysis [14], enzymatic conversion [15], and microbial
conversion [16] have been used, but these chemical methods result
in side reactions such as epimerization, hydration, and hydroxyl-
ation, and most microbial transformations do not reach a food-
grade standard.
In our previous study [17], the treatment of enzymes such as
Optidex and Viscozyme increased total sugar, uronic acid, poly-
phenol, and solid contents, and reduced the bitterness of red
ginseng extract. In addition, conversions of ginsenosides were
observed; Rb2 and Rc were converted into Rg3 or Rh2, and Rb1 wasgneung-ro, Sengbuk-gu, Seoul, 136-703, Korea.
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various hydrolytic enzymes were subsequently examined in red
ginseng extract treated by amylase, with the purpose of increasing
the amounts of ginsenoside metabolites as well as their conver-
sions into aglycones. Therefore, we investigated the effects of each
enzyme treatment on the chemical composition and the trans-
formation of ginsenosides in red ginseng extract.
2. Materials and methods
2.1. Materials
Six-yr-old red ginseng was purchased at a ginseng market in
Geumsan, Korea. Standard ginsenosides, including compound K,
Rh2, Rh1, Rg5, Rk1, Rg2, Rg3, Rg1, Rf, Re, Road, Rb2, Rc, and Rb1,were
purchased fromEmboLaboratory inDaejeon,Korea. Spezymeprime,
Optidex L-400 (Genencor International Inc., Palo Alto, CA, USA),
Viscozyme (Novo Nordisk Ferment Ltd, Dittingen, Switzerland),
Econase CE, Rapidase, Ultraﬂo L, and Cytolase PCL5 (obtained from
BisionBiochem, Sungnam,Korea)were alsoused. The characteristics
of enzymes are summarized in Table 1. All other chemicals were
obtained from local suppliers and were of reagent grade.
2.2. Preparation of Korean Red Ginseng extraction and enzymatic
conversion of Korean Red Ginseng extraction
Red ginseng powder (200 g) was suspended in 1 L of distilled
water, and the pH of the solution was adjusted to pH 6 with 2N
NaOH. Spezyme prime (4 mL) was added to the red ginseng sus-
pension. The red ginseng suspensions were incubated at 85C for
12 h. Optidex L-400 (4 mL) was added to the suspensions followed
by incubation at 60C for 4 h after Spezyme treatment for 12 h.
After hydrolysis, the reaction was terminated by boiling for 15 min
[17].
The hydrolyzed mixtures were extracted twice with 3 L of
ethanol under reﬂux in awater bath at 90C for 2 h. The extract was
then centrifuged at 10,000  g for 30 min. This supernatant was
evaporated to 10 brix. The concentrate was used for bioconversion
with enzymes.
The concentrate was used as a substrate for enzymatic conver-
sion by various enzymes. One wt% enzyme was added for a con-
version reaction in optimal conditions as illustrated in Table 1. After
the enzymatic conversion, the reaction was terminated by boiling
for 15 min. The reaction was used in assays to determine chemical
components such as polyphenols, total sugars, uronic acid, and
ginsenosides.
2.3. Determination of chemical composition in Korean ginseng
The amount of total sugar was measured by the phenolesulfuric
acid method using glucose as the respective standard [18]. UronicTable 1
Characteristics of enzymes used to hydrolyze Korean Red Ginseng
Enzyme Source Optimal temp
Spezyme prime Aspergillus niger 85e90
Optidex L-400 Geobacillus stearothermophilus 58e65
Econase CE Trichoderma sp. 55
Rapidase Aspergillus niger and Trichoderma
longibrachiatum
10e55
Viscozyme Aspergillus sp. 40e50
Ultraﬂo L Humicola insolens 40
Cytolase PCL5 Aspergillus niger 10e55acid was estimated by the 3-phenylphenol method using gal-
acturonic acid as the standard [19]. Total polyphenol content was
determined by a modiﬁed FolineCiocalteu method of microscale
using gallic acid as standard [20].
2.4. Analysis of ginsenoside contents
The solid-phase extraction sample (2mL) was prepared by using
the C18 ODS cartridge (Waters Associates, Milford, MA, USA)
described by Lou et al [21]. The levels of 16major ginsenosides were
analyzed using a high performance liquid chromatography (HPLC)-
based technique developed by Lee et al [22]. The HPLC system
(Varian Prostar 200, Reno, NV, USA) was equipped with a quater-
nary solvent delivery system, an autosampler, and an UV detector.
The column was an Imtakt Cadenza CD-C18 column
(4.6 mm  75 mm, Imtakt Co., Kyoto, Japan).
2.5. Skin permeability test
Skin permeation was determined by the method of Sonavane
et al [23], with certain modiﬁcations. Male SpragueeDawley rats,
weighing 250e300 g (Nara Bio Animal Center, Seoul, Korea), were
used for the study. The excised skin was mounted in a Franz-type
diffusion cell. Then, 4.9 mL of 0.1M sodium phosphate buffer (pH
7.4) was used as a receptor medium, and 100 mL of ginseng sample
was placed on the donor side. The receptor medium was kept at
37C and stirred with a magnetic stirrer at 400  g. The polyphenol
content of the transports was determined by the FolineCiocalteu
method [20].
2.6. Statistical analysis
In all cases, analyses were performed in triplicate, unless
otherwise speciﬁed. These values were averaged and standard
deviations were calculated. All data were analyzed by one-way
analysis of variance and Duncan’s multiple range tests using SPSS
version 10.0 software (SPSS Inc., Chicago, IL, USA). The results were
considered signiﬁcant at p < 0.05.
3. Results and discussion
We previously reported that single use of Spezyme and Optidex,
which usually act on the a-1,4 glycosidic bond, decreases the level
of bitterness with an increase of sugar contents [17], and increases
the yields of ginsenosides. To retain beneﬁcial effects of taste and
yield, ginseng extract was preferentially prepared by Spezyme and
Optidex prior to treatment of the testing enzymes, which work on
chemical bonds including b-1,4 glycosidic bonds resistant to amy-
lases. Accordingly, we investigated the effects of ﬁve enzymes on
the chemical composition and the transformation of ginsenosides
in red ginseng extract prepared with Spezyme and Optidex.erature (C) Optimal pH Main activity
6.2e6.5 a-Amylase
4.0e4.5 Glucoamylase
4.0e5.5 Cellulase
4.0e5.0 pectinase, Hemicellulase, cellulase
3.3e5.5 Arabinase, cellulase, b-Glucanase,
hemicellulase, xylanase
6.0 b-Glucanase
2.5e5.0 Pectinase
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Fig. 2. Uronic acid contents of red ginseng extracts treated with various enzymes. The
control is red ginseng extract prepared with Spezyme prime and Optidex L-400. Values
are mean  standard deviation (n ¼ 3). Means with different letters are signiﬁcantly
different at p < 0.05 by Duncan’s multiple range tests.
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Fig. 1. Total sugar contents of red ginseng extracts treated with various enzymes. The
control is red ginseng extract prepared with Spezyme prime and Optidex L-400. Values
are mean  standard deviation (n ¼ 3). Means with different letters are signiﬁcantly
different at p < 0.05 by Duncan’s multiple range tests.
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various enzymes
The total sugar content of the red ginseng extracts is presented
in Fig.1. Rapidase showed the highest level of total sugar among the
tested enzymes. It increased the amount of total sugar by around
25% compared with the control. The Ultraﬂo L treatment also
showed a higher content of total sugar than the control without a
signiﬁcant difference with a Rapidase treatment (p < 0.05). Cyto-
lase PCL5 showed a signiﬁcant increase of total sugar content
compared with the control, but Econase rather slightly decreases
the content. Rapidase has been known to contain activities of
pectinase, hemicellulase, and cellulase, suggesting that these
enzymatic activities are involved in the further liberation of sugars
after amylase treatment. This result showed further enzymatic
treatment following amylase can promote the release of sugars
from integrated compounds in red ginseng extract.
The major constituents of Korean ginseng are carbohydrates
(60e70 g carbohydrate/100 g solid), which include starch, cellu-
lose, and glycosides. Starch is a major component of ginseng car-
bohydrates [24]. The amylose content of ginseng starch varies
from 15 g to 30 g amylose/100 g starch, depending on their year
and grade [25]. Several studies suggested that the hydrolysis of
these carbohydrates enhances the extraction of active compounds
such as ginsenosides and shorter sugars [22,26]. The amylase
treatment was shown to increase total sugar contents by hydro-
lyzing the starch in red ginseng [22]. In particular, a-amylase was
used to extract saponins, oligosaccharides, and polysaccharides
from fresh or dried roots of P. ginseng Meyer and Panax quinque-
folius [27]. Tang [27] also reported that one or more of cellulases
and hemicellulases were used to break down the cell walls of
ginseng berries (e.g., P. ginseng Meyer or P. quinquefolius) to facil-
itate the extraction of triterpene saponins, oligosaccharides, and
polysaccharides.
3.2. Acidic polysaccharide contents of red ginseng extracts treated
with various enzymes
The uronic acid (as acidic polysaccharide) contents of red
ginseng extracts are presented in Fig. 2. The order of enzymaticefﬁcacy liberating uronic acid in the red ginseng extract prepa-
rations was as follows: Cytolase ¼ Econase  Ultraﬂo
L  Rapidase, Control, and Viscozyme. Cytolase and Econase
treatments showed the most liberation of uronic acid by
showing 11.9 mg/mL and 11.8 mg/mL, respectively. Rapidase and
Ultraﬂo L also released more uronic acid content (9.9 mg/mL and
10.9 mg/mL, respectively) compared with the control showing
only 8.2 mg/mL (Fig. 2).
This result suggested that additional treatment of enzymes after
amylase increases the production of acidic polysaccharides such as
uronic acid in red ginseng extract. The biological effects of acidic
polysaccharides were observed in many studies. Acidic poly-
saccharide from Korean Red Ginseng was shown to have immu-
nostimulating and antitumor activities with the activation of
natural killer cells and nitric oxide production [28,29]. Tox-
ohormone L-induced lipolysis was inhibited by acidic poly-
saccharides from ginseng root [25]. Acidic polysaccharides from
Korean Red Ginseng modulated pancreatic lipase activity and
caused a reduction of plasma triglyceride levels after oral admin-
istration of corn oil emulsion to rats, suggesting the involvement of
pancreatic lipase in the reduction of lipolysis [30].
3.3. Polyphenol of red ginseng extracts treated with various
enzymes
Polyphenolic compounds are considered to be secondary me-
tabolites synthesized in plants by a defense mechanism in response
to various stress conditions [31]. Polyphenols from plants were
known to present various biological activities such as antioxidative
and anti-inﬂammatory effects.
As shown in Fig. 3, sequential enzyme treatment did not affect
the content of polyphenols, showing a similar level to the control.
Recently, carbohydrate-hydrolyzing enzymes, such as pectinase,
cellulase, hemicellulase, and glucanase have been used to break the
cell wall complex for the extraction of polyphenolics [32,33]. These
enzymes were considered to disintegrate the plant cell wall matrix
to facilitate polyphenol extraction [34]. However, our results did
not exhibit a signiﬁcant increase of polyphenols after enzymatic
treatment on extract.
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Fig. 3. Polyphenol contents of red ginseng extracts treated with various enzymes. The
control is red ginseng extract prepared with Spezyme prime and Optidex L-400. Values
are mean  standard deviation (n ¼ 3). Means with different letters are signiﬁcantly
different at p < 0.05 by Duncan’s multiple range tests.
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various enzymes
The ginsenoside composition of red ginseng extracts is pre-
sented in Table 2. Rc was the most abundant in the control and
Ultraﬂo L groups, but the other enzymatic treatment contained Rb1
as the highest ginsenoside. Meanwhile, ginsenoside Rh2 and
compound K were not detected in all extracts. A total ginsenoside
content generated by Rapidase was the highest among the enzyme
treatments by showing 167.35 mg/mL. The treatment of other en-
zymes did not show a signiﬁcant increase in total ginsenoside
contents. In particular, deglycosylated ginsenoside metabolites
such as Rh1, Rg5, Rk1, Rg2, and Rg3 were detected the most in
Rapidase treatment. This result is correlated with the data (Fig. 1)
showing a signiﬁcant elevation of total sugar in Rapidase treatment,
indicating that Rapidase allows the increase of deglycosylated
ginsenosides by promoting the release of sugars linked to ginse-
noside glycosides. Fig. 4 shows the contents of major ginsenoside
contents. Contents of panaxadiols and panaxatriols in red ginseng
extracts were also highest in Rapidase treatment (128.53 mg/mL
and 32.36 mg/mL, respectively).
Ginsenoside Rg3, Rg5, Rg2, Rg4, Rh2, Rh3, Rh1, and Rh4 have
been shown to have special physiological activities: Rh2, Rh3, Rg3,Table 2
Ginsenoside contents of hydrolyzed red ginseng extracts using various enzymes
Ginsenoside C
Control Ultraﬂo L Rapidase
Rh1 1.26  0.06 1.29  0.09 1.35  0
Rg5 þ Rk1 4.27  0.30 2.52  0.13 6.46  0
Rg2 3.96  0.40 3.37  0.27 5.03  0
Rg3 6.10  0.59 4.94  0.30 8.42  0
Rg1 3.05  0.18 2.56  0.18 4.25  0
Rf 3.11  0.25 2.61  0.15 3.98  0
Re 12.75  0.38 9.65  0.45 17.75 
Rd 19.10  0.76 14.54  0.95 25.77 
Rb2 12.75  0.89 9.10  0.35 14.55 
Rc 37.40  1.68 27.10  1.33 35.48 
Rb1 35.56  2.31 24.73  1.73 44.32 
Compound K 0 0 0
Rh2 0 0 0and Rh1 have anticancer properties without side effects; and Rg3
and Rg2 have antithrombus effects. However, these ginsenosides
have some difﬁculties in availability because of low levels in
ginseng [35].
Ginsenosides are usually metabolized by human intestinal
bacteria to deglycosylated forms, which are more readily absorbed
in the bloodstream and act as biologically active compounds [36].
Among these deglycosylated ginsenosides, Rg3 exerts many
pharmacological activities such as tumor-suppressing [37], anti-
metastatic [38], anticarcinogenic [39], hepatoprotective [40], neu-
roprotective [41], and vasodilating effects [42]. However, the
concentration of ginsenoside Rg3 is extremely low in normal
ginseng [43]. Thus, the increase of ginsenoside Rg3 level would be
very important for the development of health-oriented products. In
addition, many studies have been performed, aiming at the increase
of minor active ginsenosides such as Rg3 via conversions of major
ginsenosides contained abundantly [16,21,22]. Our data, which
showed an increase of aglycones including Rg3 with Rapidase
treatment (Table 2), suggest that use of Rapidase in the enzymatic
process on ginseng extract will be useful in the development of
ginsengproductswith theobjective of increasing active compounds.
Kohda and Tanaka [44] reported crude preparations of several
glycoside hydrolases for the hydrolysis of ginseng ginsenosides;
cellulase and amylase exhibited very low hydrolytic activities,
whereas pectinase, naringinase, and hesperidinase had much
higher activities for hydrolyzing ginsenosides.
3.5. Skin permeability of Rapidase-treated red ginseng extract
A permeability study of Rapidase-treated red ginseng extract in
rat skin was conducted by using Franz diffusion cells. The poly-
phenol contents of the samples transported through the rat skin
was signiﬁcantly increased over time (Fig. 5). The skin permeability
of the red ginseng extract treated with Rapidase was higher than
that of the control. In particular, after 4 h, the skin permeability of
the red ginseng extract treated with Rapidase showed a signiﬁcant
increase (p < 0.05) compared with that of the control. Although
total polyphenol contents are similar in the presence or absence of
Rapidase treatment, Rapidase treatment showed a signiﬁcant
improvement of skin permeability. This result suggests that Rap-
idase can also act on polyphenol glycosides to produce aglycone
forms of polyphenols.
Recently, the study to maximize the bioactivity of plant extracts
via the enzyme reaction has been performed in the cosmetic in-
dustry using natural compounds [45]. The bioactive ingredients
of plants mostly include mixtures of compounds that are present
in the form of aglycones and hydrophilic glycosides. However,oncentration (mg/mL)
Viscozyme Cytolase Econase
.07 1.24  0.07 1.31  0.10 1.19  0.05
.39 4.17  0.20 5.27  0.38 4.93  0.15
.45 3.90  0.30 4.44  0.21 4.35  0.26
.59 6.64  0.46 7.12  0.38 6.85  0.48
.38 3.11  0.24 3.58  0.23 3.23  0.26
.32 3.43  0.23 3.40  0.25 3.60  0.22
1.24 12.50  0.96 13.24  0.75 12.93  0.56
1.55 17.80  1.05 22.28  1.02 18.39  1.34
0.44 11.31  0.54 12.17  0.65 11.30  0.70
1.42 27.19  1.11 27.48  1.57 27.44  1.65
3.10 33.62  1.98 36.32  2.18 33.61  1.34
0 0 0
0 0 0
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Fig. 4. Total ginsenoside, panaxadiols, and panaxatriols (A), and sum of Rg1 and Rb2 and metabolite contents (B) of red ginseng extracts treated with various enzymes. The control
is red ginseng extract prepared with Spezyme prime and Optidex L-400. Values are means  standard deviation (n ¼ 3). Means with different letters are signiﬁcantly different at
p < 0.05 by Duncan’s multiple range tests.
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metics attributable to their low skin permeability. By contrast,
aglycone, a hydrophobic polyphenol, can permeate human skin
[46]. Wiechers [47] reported that lowmolecular weight contributes
to easier skin penetration; there is a size limitation for chemical
compounds and drugs to be absorbed across the human skin bar-
rier. Therefore, Bos and Meinardi [48] reported that certain skin
penetration enhancers have low molecular weight. Thus, the hy-
drolysis of glycoside ingredients into their aglycone forms has
attracted attention as an effective means of enhancing the
permeability and, consequently, bioactivity of extracts [45].
Most commercial ginseng products are produced from chemical
processes such as solvent extractions and chromatographic puriﬁ-
cations. These processes are complicated, costly, and are usually
associated with low yields of active compounds such as ginseno-
sides, oligosaccharides, and polysaccharides. Enzymatic extraction
was found to be an easy and rapid method for the separation and
concentration of bioactive compounds. Therefore, Rapidase will be
a major enzyme to enhance bioactive compounds in the develop-
ment of health-oriented ginseng products via enzymatic processes.Time (h)
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Fig. 5. The skin permeability test using the Franz diffusion cell model of red ginseng
extract. The skin permeability of the ginseng sample is expressed as mg of polyphenol/
cm2 of tissue area. The red ginseng extract treated with Rapidase shows a signiﬁcant
difference compared with the control (*p < 0.05).Conﬂict of interest
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